These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7847836)

  • 21. Four quadrant fine needle aspiration cytology for the detection of benign proliferative breast lesions accompanying breast carcinoma.
    Jayaram G; Gupta M; Lamba S
    Malays J Pathol; 1993 Dec; 15(2):137-42. PubMed ID: 8065175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of scoring system in classification of proliferative breast disease on fine needle aspiration cytology.
    Mridha AR; Iyer VK; Kapila K; Verma K
    Indian J Pathol Microbiol; 2006 Jul; 49(3):334-40. PubMed ID: 17001879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast fine needle aspiration cytology. Utility as a screening tool for clinically palpable lesions.
    Costa MJ; Tadros T; Hilton G; Birdsong G
    Acta Cytol; 1993; 37(4):461-71. PubMed ID: 8328240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear grooves in fine needle aspiration (FNA) biopsies of breast lesions.
    Labropoulou P; Psachoulia C; Batistatou A; Kardari M; Scopa CD
    Anticancer Res; 1996; 16(6C):3959-63. PubMed ID: 9042320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoscopic ultrasound-guided fine-needle aspiration biopsy of liver lesions: histological and cytological assessment.
    Hollerbach S; Willert J; Topalidis T; Reiser M; Schmiegel W
    Endoscopy; 2003 Sep; 35(9):743-9. PubMed ID: 12929021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow cytometric DNA-analysis of cells obtained with fine needle aspiration biopsy of the breast.
    Niezabitowski A; Lackowska B; Gruchala A; Ryś J; Jaszcz A; Szklarski W; Wasilewska A; Herman K
    Gen Diagn Pathol; 1996 Jun; 142(1):33-9. PubMed ID: 8793484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fine-needle aspirates of granular cell lesions of the breast: report of three cases, with emphasis on differential diagnosis and utility of immunostaining for CD68 (KP1).
    Sirgi KE; Sneige N; Fanning TV; Fornage BD; Ordóñez NG; Swanson PE
    Diagn Cytopathol; 1996 Dec; 15(5):403-8. PubMed ID: 8989543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation.
    Alkuwari E; Auger M
    Cancer; 2008 Apr; 114(2):89-93. PubMed ID: 18286535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA ploidy and TLI in association with other prognostic parameters in breast cancer.
    Midulla C; Cenci M; De Iorio P; Pisani T; Bonaccorsi A; De Marchis L; Nofroni I; Vecchione A
    Anticancer Res; 1999; 19(1A):381-4. PubMed ID: 10226571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fine needle aspiration biopsy (FNAB) of breast lumps: comparison study between pre- and post-operative histological diagnosis.
    Abu-Salem OT
    Arch Inst Pasteur Tunis; 2002; 79(1-4):59-63. PubMed ID: 15072246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing core needle to surgical biopsies in breast cancer for cell kinetic and ploidy studies.
    Daidone MG; Orefice S; Mastore M; Santoro G; Salvadori B; Silvestrini R
    Breast Cancer Res Treat; 1991 Sep; 19(1):33-7. PubMed ID: 1756265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliability of 3H-thymidine labeling index: cell proliferation of colorectal carcinoma in three different centers.
    Ponz de Leon M; Costa A; Lanza G; Scalmati A; Roncucci L; Faranda A; Di Gregorio C; Fante R; Colella G; Silvestrini R
    Mod Pathol; 1991 Sep; 4(5):627-31. PubMed ID: 1758875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen receptor analysis on needle aspirates from human mammary carcinoma.
    Silfverswärd C; Humla S
    Acta Cytol; 1980; 24(1):54-7. PubMed ID: 6928336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymidine labeling index: prognostic role in breast cancer.
    Bilir A; Ozmen V; Kecer M; Eralp Y; Cabioglu N; Ahishali B; Camlica H; Aydiner A
    Am J Clin Oncol; 2004 Aug; 27(4):400-6. PubMed ID: 15289735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymidine labeling index and Ki-67 growth fraction in lesions of the breast.
    Kamel OW; Franklin WA; Ringus JC; Meyer JS
    Am J Pathol; 1989 Jan; 134(1):107-13. PubMed ID: 2536520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The errors of thymidine labelling in breast cancer.
    Smallwood JA; Cooper A; Taylor I
    Clin Oncol; 1983 Dec; 9(4):331-5. PubMed ID: 6661855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth kinetics of human colorectal carcinoma.
    Ota DM; Drewinko B
    Cancer Res; 1985 May; 45(5):2128-31. PubMed ID: 3986766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferative activity of human solid tumors evaluated by thymidine labeling index and primer-dependent alpha-DNA polymerase.
    Alama A; Conte PF; Di Marco E; Favoni RE; Nicolin A
    Oncology; 1986; 43(6):385-9. PubMed ID: 3808572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinoma in situ.
    Barnes DM; Meyer JS; Gonzalez JG; Gullick WJ; Millis RR
    Breast Cancer Res Treat; 1991 Mar; 18(1):11-7. PubMed ID: 1677296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of the Tritiated Thymidine Labeling Index in breast cancers.
    Araki K; Kimura M; Sakamoto K; Nishimura R; Akagi M
    Jpn J Surg; 1985 Mar; 15(2):144-9. PubMed ID: 4010096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.